# Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

> **NCT06964685** · — · RECRUITING · sponsor: **Abiomed Inc.** · enrollment: 350 (estimated)

## Conditions studied

- AMI Cardiogenic Shock

## Interventions

- **DEVICE:** Impella

## Key facts

- **NCT ID:** NCT06964685
- **Lead sponsor:** Abiomed Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-10-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06964685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06964685, "Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06964685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*